0001666071-21-000127.txt : 20210603 0001666071-21-000127.hdr.sgml : 20210603 20210603204149 ACCESSION NUMBER: 0001666071-21-000127 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210602 FILED AS OF DATE: 20210603 DATE AS OF CHANGE: 20210603 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Grimes Scott D. CENTRAL INDEX KEY: 0001617486 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38386 FILM NUMBER: 21994513 MAIL ADDRESS: STREET 1: CARDLYTICS, INC. STREET 2: 675 PONCE DE LEON AVENUE NE, SUITE 6000 CITY: ATLANTA STATE: GA ZIP: 30308 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cardlytics, Inc. CENTRAL INDEX KEY: 0001666071 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMPUTER PROGRAMMING, DATA PROCESSING, ETC. [7370] IRS NUMBER: 263039436 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 675 PONCE DE LEON AVENUE, NE STREET 2: SUITE 6000 CITY: ATLANTA STATE: GA ZIP: 30308 BUSINESS PHONE: 888-798-5802 MAIL ADDRESS: STREET 1: 675 PONCE DE LEON AVENUE, NE STREET 2: SUITE 6000 CITY: ATLANTA STATE: GA ZIP: 30308 4 1 wf-form4_162276728241676.xml FORM 4 X0306 4 2021-06-02 0 0001666071 Cardlytics, Inc. CDLX 0001617486 Grimes Scott D. C/O CARDLYTICS, INC. 675 PONCE DE LEON AVENUE NE, SUITE 6000 ATLANTA GA 30308 1 0 0 0 Common Stock 2021-06-02 4 S 0 1016 105.53 D 80096 I See Footnote Common Stock 2021-06-02 4 S 0 885 106.29 D 79211 I See Footnote Common Stock 2021-06-02 4 S 0 99 107.36 D 79112 I See Footnote Common Stock 242674 D These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the trustee of the 2013 Scott Grimes GRAT UAD (the "GRAT") on November 15, 2019, as amended March 12, 2020. The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $104.97 to $105.70, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), and (4) to this Form 4. The reportable securities are held by the GRAT. The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $106.23 to $106.45, inclusive /s/ Kirk Somers, Attorney-in-Fact 2021-06-03